Hemay005: Clinical Trials

10 trials of Hemay005, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 2 unknown, 1 recruiting. 10 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 110Completed 7, Unknown 2, Recruiting 1

Follow Hemay005: new trials by email Literature Review of Hemay005 trials Research Report on Hemay005

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation the Safety of hemay005 Tablets
Hemay005 tablet, Placebo - Chronic Obstructive Pulmonary Disease
Phase 1CompletedAnhui Hemay Pharmaceutical Co., Ltd4682024-12-252025-12-09
Pharmacokinetic Interactions Between Hemay005 Tablets and Midazolam Maleate Tablets
Hemay005, Midazolam maleate - Psoriasis
Phase 1CompletedGanzhou Hemay Pharmaceutical Co., Ltd202024-12-122025-12-03
Bioequivalence Test of Hemay005 Tablets
Hemay005 - Psoriasis
Phase 1CompletedGanzhou Hemay Pharmaceutical Co., Ltd282024-09-152025-03-18
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Patients With Renal Impairment
Hemay005 - Psoriasis
Phase 1CompletedGanzhou Hemay Pharmaceutical Co., Ltd262024-05-072025-12-04
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
Hemay005 - Psoriasis
Phase 1RecruitingGanzhou Hemay Pharmaceutical Co., Ltd242024-04-282025-12-04
A Study to Evaluate the Effects of Single and Multiple Doses of Hemay005 Tablets in Health Caucasian Adult Volunteers
Hemay005 60 mg - Healthy
Phase 1CompletedGanzhou Hemay Pharmaceutical Co., Ltd122023-07-172024-03-01
Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects
Hemay005 - Psoriasis
Phase 1CompletedTianjin Hemay Pharmaceutical Co., Ltd122021-04-292024-03-06
A Food Effect Study to Assess Pharmacokinetics of Hemay005 in Healthy Volunteers
Hemay005 - Psoriasis
Phase 1UnknownTianjin Hemay Bio-Tech Co., Ltd122018-10-102018-07-05
Multiple Ascending Dose Study to Assess Safety and Pharmacokinetics of Hemay005 In Healthy Subjects
Hemay005, Placebo - Psoriasis
Phase 1UnknownTianjin Hemay Bio-Tech Co., Ltd242018-07-102018-10-02
Safety and Pharmacokinetics of Hemay005 In Healthy Male Subjects
Hemay005, Placebos - Psoriasis
Phase 1CompletedTianjin Hemay Bio-Tech Co., Ltd682016-12-012018-06-19

Conditions studied

Psoriasis (8)  ·  Pulmonary Disease, Chronic Obstructive (1)

Sponsors

Ganzhou Hemay Pharmaceutical Co., Ltd (5)  ·  Tianjin Hemay Bio-Tech Co., Ltd (3)  ·  Anhui Hemay Pharmaceutical Co., Ltd (1)  ·  Tianjin Hemay Pharmaceutical Co., Ltd (1)

Countries

China (8)  ·  Australia (1)

Top investigators

Hongyun Wang, Doctor (2)  ·  Weiyong Li (2)  ·  Christopher J Argent (1)

Results publications

PMID 41545329